← Scoopfeeds — Intelligent news, curated.
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
business

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?

Yahoo Finance · May 11, 2026, 8:35 PM · Also reported by 2 other sources

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?

Read full story on Yahoo Finance → More top stories

Also covered by

Grist Wall Street is betting big on clean energy tech Investing.com United Therapeutics CFO James Edgemond sells $5.7m in stock

More in business

MarketWatch
‘He is retired’: Should my husband take his Social Security at 62 and invest it?
Investing.com
Cruise card spending jumps 15.8% in April, Bank of America data shows
Investing.com
UBS delays Fed rate cuts on inflation concerns, as jobs stay resilient
Investing.com
Rights groups urge Poland to halt support for US deportation flights to Ukraine
CNBC
China's Tencent sees boost from gaming, AI demand even as revenue comes in weaker than expected
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop